Professor Jean-Marie Kabongo Mpolesha
Professor Jean-Marie Kabongo Mpolesha was born in Mikalayi, Democratic Republic of Congo. He received his MD Diploma from the University of Zaire in 1976, Diploma in Pathology from the University of Kinshasha in 1994 and a PhD also from the University of Kinshasa in 2003.
He has published many articles in peer-reviewed journals and is a member of the Académie Internationale de Pathologie (AIP), Division Française et Division d’Afrique Francophone (DAF); Association Panafricaine des Pathologistes and the Association des Professeurs de l’Université de Kinshasa Apukin.
Professor Cristina Stefan
Cristina Stefan is the Vice President South African Medical Research Council. Professor Stefan completed oncology and pediatrics fellowships and masters, masters in cancer epidemiology and PhD in education a few years later. She was a fellow at St Jude Children’s Cancer Research Hospital and received a fellowship in cancer prevention and control at NCI.
She was also a fellow of cancer registration and epidemiology program at IARC in Lyon where she was invited to teach about cancer in developing countries.
Professor Stefan published 1 book (2 others in press- in oncology), 9 chapters in books, a number of articles and being also involved in many clinical trials. She is active internationally in the field of cancer registration, continuous education of cancer specialists, cancer control guidelines, twinning and research activities in 18 African countries. She speaks French fluently and understands Portuguese. Prof Stefan had the first initiative in the world to introduce a “twinning” concept between 2 African countries (South Africa and Namibia) and showing success.
Prof Stefan was formerly AORTIC vice-president for Southern Africa, founder of the African Cancer Institute, chair and founder of African Cancer Economics Network, chair of AORTIC pediatric oncology and co-chair research committee
IMMEDIATE PAST PRESIDENT
Professor Ahmed Elzawawy
Internationally and in Africa:
President of the International Campaign for Establishment and Development of Oncology Centers (ICEDOC) & ICEDOC’s Experts in Cancer Without Borders, a non-governmental organisation, registered in Texas, USA. Co- President and Director of South and East Mediterranean College of Oncology (SEMCO).
Member on the Special panel, Advisory Board, International network for cancer treatment and research (INCTR) & Member of INCTR’s Breast Cancer Strategy Group.
Locally in Egypt :
- Chairman & Professor of Clinical Oncology (Radiation and Medical Oncology) and Nuclear Medicine department, Faculty of Medicine, Suez Canal University Hospital, Ismailia, Egypt. I am a Professor of clinical oncology since 1992. Before that date I was Assistant Professor (1987), and Lecturer (1983-1987) in the same faculty of medicine, Suez Canal University. I therefore have more than 25 years experience in university education.
- Chairman and senior consultant of Al Soliman Radiation Oncology Centre (ASROC) Al Soliman Hospital, Port Said, Egypt (since its foundation in 1993, till present).
- Consultant and Supervisor of Cancer Chemotherapy Unit, Port Said General Hospital, Egypt. (Since 1983 till present).
- I am also one of the six senior professors who are members of the Permanent Scientific Committee appointed by the Supreme council of Egyptian Universities and the decree of The of Minister of High Education in Egypt. This committee evaluates researchers, university teaching and clinical work of all candidates for the posts of professors and associate professors in Clinical Oncology, Surgical Oncology and related clinical disciplines in all the Egyptian Universities.
Professor Lynette Denny
Lynette Denny is a gynaecological oncologist working as a principal specialist and Head of Department of Obstetrics & Gynaecology at Groote Schuur Hospital/University of Cape Town. Her work includes clinical service, teaching and training and research. Her two main research interests have centred around prevention of cervical cancer in low resource settings and violence against women.
In the former, she has collaborated with researchers from Columbia University in New York in three large community-based cervical cancer screening projects located in informal housing settlements outside Cape Town since 1996. This work has been funded by Engender Health and the Bill & Melinda Gates Foundation. To date over 18 000 indigent women have been screened in this project, which has just completed a randomised trial of screening and treatment using visual inspection and HPV DNA testing as primary screening tests.
She is currently conducting a randomised trial of the safety and immunogenicity of the bivalent HPV vaccine in HIV Positive women.
She was appointed Secretary Treasurer of AORTIC in 2003 and has held this position to date. She has organised two very successful conferences and is busy organising the third AORTIC international conference and has been instrumental in building up the infrastructure and capacity of the organisation.
Professor Denny has received a number of awards, including being the first recipient of the Shoprite Checkers/SABC 2 Woman of the Year award for Science and Technology in 2003. She has published in international peer reviewed journals and is a member of a number of international committees in her field of gynaecological oncology.
SECRETARY TREASURER ELECT
Dr Verna Vanderpuye
Dr. Verna Vanderpuye is dually trained in medical and radiation oncology. She is a Consultant Oncologist and Faculty Chair at the Ghana Postgraduate Medical College, and is a lecturer in the medical school and School of Allied Health Sciences, University of Ghana, Accra.
Her primary interests are in female cancers, gastrointestinal, genitourinary tumors and sarcomas. She is a tireless advocate for palliative care, as about half of all cancer patients in Ghana have advanced disease at diagnosis.
Her goal is to improve, standardize and bridge the gap in the management of cancers in developing countries, through education and training of physicians and other supporting health staff. She has presented in more than 30 national and international cancer conferences, authored more than 28 journal articles and book chapters, and serves on various international , local oncological societies and academic committees including ASCO, ESMO, and AORTIC.
Vice-President: Central Africa
Professor Judith Nsonde Malanda
Université Marien NGouabi : Medical Officer – Medical Oncology Specialist, University Teaching Hospital of Brazzaville, Associate Lecturer, Faculty of Health Sciences, Assistant Professor of Medical Oncology
2012 - CAMES 2012 Senior Lecturer, Marien Ngouabi University Brazzaville - Since 2000, certified trainer in cervical cancer screening methods with visual inspection and technical expert at WHO (IARC Lyon). Since 2002, permanent lecturer at Marien Ngouabi University. From 2005, participated in several educational seminars on capacity building in training (15).
Since 2005, active member of AORTIC, regularly paying annual dues and participing in various AORTIC conferences. In community life, active member of Congolese Union against Cancer, official of cancer control at Calissa Ikama Cancer Foundation, member of “Association Congolaise Accompagner”, board member of the ALLIANCE against cancer Paris 2013, has organized cancer awareness campaigns and contact person (expert) in the drafting of the 2013-2017 Cancer Control Strategic Plan in Congo.
Since 1998, has presented 54 scientific papers at national and international conferences on oncology, including prevention, treatment and palliative care.
Since 1998, 40 scientific publications in scientific journals on medical oncology
2011: Member of the Management Committee of the cancer registry of Brazzaville.
Vice-President: East Africa
Dr Louis Ngendahayo
Dr Louis Ngendahayo graduated from the University of Burundi in 1983 and completed the training in Anatomic Pathology (MMed degree) in Paris, France in 1990. He holds also a master’s degree in Histology-Embryology. His main research and clinical interest has been in gynaecologic and gastrointestinal pathology. He has over 15 publications and is member of the East African Division of the International Academy of Pathology.
Current, he holds the position of Associate Professor at the faculty of Medicine, University of Burundi. He is in charge of teaching anatomic pathology and histology in the undergraduate programme
During the period of 1992- 2001, in addition to his clinical and academic career, he has had several major leadership positions in management of the faculty of medicine at the University of Burundi, Bujumbura and at the National University of Rwanda, Butare.
Since 1998 up to 2012, he has been increasingly involved in the development of Pathology laboratory in the University Teaching Hospital of Butare , South province of Rwanda. He has also been closely involved in the creation and development of the Kigali Cancer Registry in Rwanda. He joined the AORTIC organisation in 2005 and attended the biennial conference in Dakar 2005 and in Dar el salaam 2009.
Vice-President: Southern Africa
Dr Doreen Ramogola-Masire
Dr. Doreen Ramogola‐Masire, is an Associate Professor of Obstetrics and Gynaecology at the University of Botswana. She has interest in point of care screening modalities that are suited to low resource settings, and has extensive experience establishing and managing cervical cancer screening programs in Southern Africa. Over the last seven years she has helped establish a comprehensive cervical cancer prevention and treatment program in Botswana, culminating with the roll out of the national HPV vaccination program beginning February 2015.
Dr Ramogola-Masire is also actively involved regionally and internationally in efforts to advance cervical cancer prevention. Her outstanding interpersonal skills, track record in advocacy and implementation, as well as a great understanding of the local and regional needs, makes her an ideal candidate to serve the Southern African community.
Vice-President: North Africa
Dr Karima Elshamy
Dr. Karima Elshamy has a doctorate degree in nursing science from Cairo University, Egypt (D.N.Sc). She is a Professor of Medical Surgical Nursing and Head of Critical Care and Emergency Nursing Department, Faculty of Nursing, Mansoura University, Egypt.
She has more than eighteen years in teaching experience for under and postgraduate students. She represented nursing for North Africa in AORTIC since 2009 – 2011, and from 2011 - 2013 she was AORTIC Vice President of Oncology Nursing. Dr. Karima is a member of the Editorial Board of the Journal of Cancer Policy.
She is Accreditation Reviewer in Ministry of health, Egypt from 2004 till now and shared in reviewing and accreditation of more than 300 health agencies. Dr. Karima Elshamy is a trainer in FLDP project of Mansoura University, Egypt. She is also a trainer for all nursing categories all over Egypt and outside Egypt. She is a founder and executive director of the Egyptian Society for Promotion of Women’s Health (ESPWH). She is an expert and consultant of infection control and has been asked to assess and investigate healthcare associated infections in governmental and non-governmental organizations, and to design infection control protocols in various healthcare settings.
Dr. Karima Elshamy’s focus work and research experience is: the prevention and control of diseases through awareness and early detection programs especially for cancer, cardiac, hypertension and occupational diseases. Also for infection control, quality and accreditation
Prior to her academic work, she has worked as a manager of cardiothoracic intensive care unites Cairo University, Egypt for more than 15 years and has extensive experience in open heart and chest surgeries.
Vice-President: West Africa
Dr J Olufemi Ogunbiyi
Dr. J. Olufemi Ogunbiyi is Professor of Anatomical Pathology at the University of Ibadan, Nigeria and Consultant Pathologist to the University College Hospital (UCH). He is also the Director of the Ibadan Cancer Registry, a population-based registry established in 1960, that currently covers a population of 2.8million persons spread over 11 local government areas of the state. He graduated from the College of Medicine of the University of Lagos (CMUL) in 1983 and subsequently obtained the fellowship of the West African Postgraduate Medical College in Laboratory Medicine (FWACP, Lab. Med) in 1990 after residency training at the UCH.
He joined the Faculty as an academic staff in December 1990 and rose to become Professor in October 1999.
He was awarded the International Fellowship of The College of American Pathologists (IFCAP) in 2007. He is a member of several professional associations and has been an active member of the editorial boards of some local and international journals. He is an active member of the British Division of the international Academy of Pathology and Fellow of the West African College of Physicians, which he served as Secretary General and Faculty Chief Examiner, and still serves as College Faculty Secretary and Chapter Faculty Chairman.
He is the foundation president of the West African Division of the International Academy of Pathology, which was inaugurated in October 2006 and served in that position for 6 years. His research interest has been in Cancer with special interest in Liver, Lung and Prostate cancers. He has trained many specialist pathologists, some of whom have very senior academic positions in Universities within and outside of Nigeria and continues to supervise Fellowship dissertations and lead research in his field, with over 70 publications in peer-reviewed journals, including cancer registry data showing trends over time.
Dr Maimuna Mendy
Dr Maimuna Mendy has been Head of Laboratory Services and Biobank Group at the International Agency for Research on Cancer (IARC) since September 2010. Prior to this appointment, she worked at the (UK) MRC laboratories in the Gambia as a Virologist and Head of Hepatitis Research. She was also Coordinator of the Laboratory Management Team at MRC responsible for the MRC biobank in the Gambia.
Dr Mendy is the IARC coordinator for the Low-and Middle-Income Biobank and Cohort Network (BCNet). The aim of BCNet is to provide a platform for collaboration between its partners, IARC and the international community, to support biobanking and cohort-building activities, and to develop sustainable biobanking research infrastructures to facilitate the collection of high-quality biological samples for research, using best practice principles and guidelines.
Dr Mendy’s research experience is extensive. Recent studies include the natural history of HBV infection and the characterization of HBV viral genotype and phylogenetic analysis. She investigated the role of Virus (HBV and HCV) and environmental factors in the ethiology of hepatocellular carcinoma (HCC) and she developed and applied a novel oligonucleotide ligation assay to detect point mutations in HBV core in chronic carriers and patients with liver diseases.
Dr Mendy is a member of the Executive Council and Principal Investigator for the Prolifica Project (EU-FP7 Grant) (2011-2015). She is a co-applicant in the EU-FP7 BBMRI-LPC project, a Member of BBMRI-ERIC assembly of members representing IARC and has recently been invited to join the AORTIC Council as Vice President for Europe. She is a member of a number of international organizations and societies including, the Institute of Biomedical Sciences (Fellow) and the Royal Society of Tropical Medicine and Hygiene (Fellow).
Vice-President: North America
Dr Nazik Hammad
Dr Nazik Hammad, M.D., M.Sc., grew up in central Sudan in the White Nile area. She had her early and secondary education in Sudan and is a graduate of the Faculty of Medicine, University of Khartoum. She has a M.Sc. in immunology from the University of Toronto. She did her internal medicine residency, and hematology/oncology fellowship at Wayne State University, Detroit, Michigan.
She was a faculty member at the Karmanos Cancer Center at Wayne State University, Detroit Michigan and is currently an Assistant Professor at the Department of Medical Oncology at Queen’s University, Kingston, Ontario, where she is also the program director for the medical oncology training program. She is a member of the Canadian Royal College of Physicians and Surgeons Medical Oncology subspecialty Committee.
Dr Hammad’s research interests are mainly in gastrointestinal cancers and in particular translational research in colorectal cancer. She is also has a keen interest in medical education, in particular health professions education in low and middle income countries. She is currently doing a Master in Medical Education in the Health Professions (MEHP) at Johns Hopkins University. She has taught at the Clinical Oncology Training Program, University of Khartoum, Sudan (Khartoum Radiation and Isotope Center) when in Sudan.
Affiliation: Queen’s University
Dr Abimbola Oluwatosin
Abimbola Oluwatosin is a registered nurse/midwife with the Nursing and Midwifery Council of Nigeria (NMCN) and a Senior lecturer at the Department of Nursing, University of Ibadan, Nigeria.
Abimbola became a fellow of Union for International Cancer Control (UICC) after winning the international Oncology Nursing Fellowship (IONF) award in 1999, which she utilized at MD Anderson Cancer center, Houston Texas. This award supported and enhanced her Ph.D thesis titled Breast cancer awareness programme: effects on utilization of early detection measures among rural women in Akinyele Local government area of Oyo State.
She developed a culture sensitive breast cancer awareness programme, that has impacted breast cancer awareness in some rural communities in Ibadan. She attended the World Cancer Congress in Geneva in 2008. At AORTIC (2009) she made an oral presentation of her work on women’s risk factors for breast cancer and predictors of the practice of breast examination in Ibadan.
Abimbola has several publications in peer review journals of international repute. As a community health nurse specialist her major research focus is women cancers with emphasis on utilization of early detection measures. She has published works on early detection measures of breast and cervical cancer; findings have implicated lack of knowledge as a major challenge to acceptance of early detection measures. These have birthed an exploratory study on client teaching of early detection of cancer among primary health care nurses.
Abimbola is a member of Global Cancer Community, Sigma Theta Thau, Honour Society of Nursing, North American Nursing Diagnosis Association International (NANDAI), African Network, a fellow of UICC and SOCRON among others. She is currently the chairperson for the NMCN Oyo state Continuing educational programme and has served as an Acting Head of her Department, 2008-2010.
Council Member at Large
Ms Barrie Adedeji
Barrie Adedeji is a Certified Public Accountant in private practice and Financial Controller/Treasurer of AORTIC in New York. She is also Executive Director of ENHICA International, Inc. and has developed and organized workshops and seminars that address health and environmental issues in Africa and the Caribbean. She was a member of the steering committee that organized the AORTIC conference in Accra, Ghana in 2003, and is a member of the fund raising committee for AORTIC in the United States.
Barrie sits on the board of several health-related institutions and acts as mentor/advisor to professional women’s groups in the international community. She has also served on the Budget and Finance Committee of New York’s Riverside Church.
Ms. Adedeji attended New York University and completed her graduate work in Intercultural Service, Leadership and Management with concentrations in Sustainable Development and Conflict Transformation at The School for International Training in Vermont.
Council Member at Large
Professor Dafalla Omer Abuidris
All levels of education in Sudan except for postgraduate which was received South Africa where fellowship was awarded. Work as faculty member at the University of Gezira, National Cancer Institute. Associate professor of clinical oncology.
Publications in peer review journals at level of Sudan, Regional and international.
Published book on cancer and it’s treatment. Many initiatives in cancer control in Sudan. Member on board of breast cancer control in Sudan.
Vice president of Sudanese society of clinical oncologists. Member of AORTIC since 2007. Presented many papers at AORTIC meetings. Supervisor in postgraduate studies for MAc and M.D. students. Vice president of Sudanese medical specialisation board (oncology section) Member of urology section in Sudanese medical board. External examiner in clinical oncology within and beyond Sudan.
Council Member at Large
Professor Isaac Adewole
Professor Isaac Adewole is currently Vice-Chancellor of the University of Ibadan, Nigeria. He undertook a research fellowship in the Department of Medical Oncology at Charring Cross Hospital in London (1985-86). He was Dean of the Faculty of Clinical Sciences & Dentistry (2000-2002), and Provost at the College of Medicine, University of Ibadan from 2002-2006.
Professor Adewole is Principal Investigator of the Harvard PEPFAR (APIN Plus) programme at the University College Hospital, Ibadan and Chairman of the PMTCT National Task Team Subcommittee on anti-retrovirals. He is also the country’s Principal Investigator for ‘Operation Stop Cervical Cancer’ in Nigeria. Secretary-General of the Confederation of African Medical Associations and Societies (CAMAS) from 1997-2003.
Professor Adewole holds memberships of many learned societies, including the Nigerian Medical Association, the Society of Gynaecology & Obstetrics of Nigeria, International Federation of Gynecology and Obstetrics (FIGO), International AIDS Society (IAS), and the International Gynecological Cancer Society(IGCS) and the African Organisation for Research and Training In Cancer (AORTIC).
Professor Adewole’s research interests include evaluating strategies for promoting cervical cancer prevention in developing countries, a multi-country study on HPV in cervical cancer among African women. He has published numerous articles in peer-reviewed journals and books on gynaecological oncology, abortion, HIV/AIDS and perinatal medicine. He is the Guttmacher Institute’s 2008 Bixby Leadership Fellow in Reproductive health and the current chair of the sub-Saharan African Cervical Cancer Working Group (CCWG).
Council Member at Large
Professor Olufunmi Olopade
Dr Olufunmilayo Falusi Olopade graduated with distinction from the College of Medicine, University of Ibadan, Nigeria, in 1980. She subsequently did her house job at the University College Hospital Ibadan after which she proceeded to the Nigerian Navy Hospital, Lagos for her National Youth Service Corps.
She left for the United States of American soon thereafter and studied Internal Medicine at the famous Cook County Hospital in Chicago, Illinois where she was named Chief Resident in 1986. Upon completion of her Hematology/Oncology Fellowship training at the University of Chicago, she was appointed to the faculty in 1991 in recognition of her brilliance and talent.
In 1992, she was appointed the Director of the Cancer Risk Clinic, and in 1998, she was appointed Director of the Fellowship Program in the Section of Hematology/Oncology of the same institution. Dr Olopade is now the Director of the Center for Clinical Cancer Genetics in the Department of Medicine and holds many other faculty, hospital, and administrative posts.
Dr Olopade received the “Phenomenal Woman Award” in recognition of her work within the African American community. She received the Heroes in Health care award from the Access Community Network in 2005. Also, as recently as September 2005, Dr Olopade was awarded the prestigious McArthur Fellows program.
Council Member at Large
Dr Fernando Miguel
Fernando Miguel was born in Damba, Republic of Angola. He received his MD Diploma from the University of Palackeho Olomouc, Czech Republic in 1991, Diploma in General Surgery and Oncological Surgery at Charles University in Prague in 1991- 1997, Master in Mastology from Universidad Internacional Menendez Pelayo in 2007 – 2009, expert in oncoplastic surgery from Complexo hospitalario Universitario da Universidad da Coruña in 2012.
Currently general manager of Angolan Institute of cancer control.
Council Member at Large
Professor Serigne Magueye Gueye
Serigne Gueye, MD, FWACS – is a Professor of Urology at University Cheikh Anta DIOP in Dakar, Senegal and Chair and consultant Urologist – Andrologist at Grand Yoff General Hospital.
Dr Gueye graduated from University Cheikh Anta DIOP in 1985 where he earned a Medical degree and completed his surgical and urology training at University of Dakar teaching hospitals. He joined University of Dakar School of Medicine as faculty member in January 1988.
He completed in Bordeaux and Paris, France fellowships in Urologic oncology and pediatric urology (1989-1992).
Dr Gueye became Associate Professor of Surgery/Urology in 1996 and was appointed Full Professor of Urology in 2000. Thereafter, he moved to Grand Yoff General Hospital in Dakar as chairman of the newly opened Department of Urology.
He is former Fulbright senior scholar at University of Pennsylvania School of Medicine, Philadelphia, PA. He is an expert in Medical Pedagogy for the CIDMEF (International Conference of Deans of Francophone Medical Schools.
His main research activities are in the field of uro-genital malignancies especially on prostate cancer in men of African descent and bladder cancer. He is Principal Investigator of an NIH/NCI funded project on molecular epidemiology of prostate cancer in Africans.
In Collaboration of Dr Timothy Rebbeck at the CCEB University of Pennsylvania School of Medicine, he as set up research facilities in Dakar under a program named “PROGRES” (Prostate Genetic Research Senegal). He is broadly involved in a variety of clinical, scientific and social endeavors.
He has extensive community commitment serving on many national, regional and international academic society committees. Dr Gueye is member of the Council of the West African College of Surgeons and has been elected as member of the Board of chairmen of the SIU since 2007.
He is currently President of African Organization for Research and Training in Cancer (AORTIC) and the Pan African Association of Urological Surgeons (PAUSA). Dr Gueye has published numerous peer-review articles in International journals.
He served as field surgeon during the Rwandese genocide under the banner of the United Nations Assistance Mission in Rwanda (UNAMIR) and has been awarded the United Nations Medal for Peace in Rwanda. Dr Gueye holds many national and international medals in Senegal, in France and Chad Republic. Serigne Gueye’s professional life is dedicated to patient care, research and training health care workers especially in Africa.
Council Member at Large
Professor Folakemi Odedina
Prof. Folakemi T. Odedina, PhD is Professor of Pharmacy, Director of the Prostate Disease Center Outreach Program, and Associate Director of Health Disparities for Shands Cancer Center at the University of Florida. Her research program focuses on understanding and developing interventions to reduce the disproportionate burden of prostate cancer among Black men globally.
Through her research program, she has facilitated global collaborations among scientists, clinicians, survivors and advocates to better understand the etiology of prostate cancer. Her accomplishments include: the Biennial conference on the Science of Global Prostate Cancer Disparities; U.S. Fulbright Scholar Award to promote cancer awareness in Africa (2006/2007); and a National Cancer Institute grant to support cancer advocacy in Africa.
The later provided travel awards to about 20 African cancer advocates to participate in the 1st AORTIC Cancer Advocacy workshop this year. Prof. Odedina’s landmark research has been recognized by many organizations, including the American Association for Cancer Research and the Department of Defense Prostate Cancer Research Program.
Her work has also been featured in multiple medical news including the Medscape Medical News and Oncology News. Prof. Odedina founded and leads the Florida Prostate Cancer Disparity Group and the Prostate Cancer Transatlantic Consortium. She also serves on several international cancer committees.
Council Member at Large
Professor Sulma I Mohammed
Sulma Mohammed, DVM, MS, PhD. Dr Mohammed earned her MS and PhD degrees from Cornell and Purdue University, USA, respectively. She is a dual citizen of Sudan and United States of America. Dr. Mohammed is Assistant Professor of Cancer Biology, Director of Purdue University Cancer Center Drug Discovery Shared Resource, and Adjunct Professor of Medical Microbiology at Indiana University School of Medicine.
Dr. Mohammed was a Walther Cancer Institute fellow and American association for Cancer Research-Cancer Research Foundation of America- Prevention Research Fellow.
Dr. Mohammed has a well funded laboratory (1 million US Dollars) to conduct studies on breast and bladder cancer. One of her research projects focuses on identification of models to study ER-negative breast cancer development and progression in women, especially African-American and African women (the majority of African and African-American women develop ER-negative tumors at a young age). Up to now, no specific treatment regime is found to treat ER-negative tumors as their counterpart ER-positive tumors.
In addition, Dr. Mohammed is working to identify biomarkers for early detection of breast cancer metastasis using proteomic-based approaches. Lately, she developed an interest in cervical cancer in collaboration with oncologists from Nigeria and Emory University, US. Dr. Mohammed has received a number of awards, including African American Institute award, African women leaders in science award, and many American Association for Cancer Research travel awards. She has published her research findings in reputable journals that include Cancer Research and Molecular Cancer Therapeutic journals. She is a member of the editorial board of the Cancer Chemoprevention journal.
Council Member at Large
Professor Timothy R. Rebbeck
Timothy R. Rebbeck, PhD, is Professor of Epidemiology, CCEB Senior Scholar, Director of the Center for Genetics and Complex Traits, Director of the Center for Population Health and Health Disparities, Director of the Laboratory for Molecular Epidemiology, and Associate Director for Population Science in the Abramson Cancer Center. His research focuses on the genetic and molecular epidemiology of cancer.
He has directed multiple molecular epidemiologic studies to identify and characterize genes that are candidates for involvement in cancer etiology, and to describe the relationship of allelic variation of these genes with biochemical or physiological traits, cancer occurrences, and cancer outcomes. These studies have been undertaken to obtain a better understanding of the relationship between genetic, demographic, biochemical, environmental, and physiological risk factors and cancer in human populations.
Dr. Rebbeck’s research uses a multidisciplinary approach that combines methods from epidemiology, statistics, molecular biology, and classical genetics.
Council Member at Large
Dr Paul Ndom
Dr Ndom is a lecturer at the Faculty of Medicine and Biomedical Sciences (FMSB) and is Head of the Medical Oncology Service of Yaounde General Hospital. He is the Director of INCTR in Cameroon (www.inctr.org) and Permanent Secretary of the EURO-AFRICAN Congress of Oncology.
He is also the assistant Permanent Secretary of the National Cancer Control Committee in Cameroon and the founding President of a Non-governmental Organisation called Chemotherapy Solidarity (SOCHIMIO) (www.Sochimio.org).
Dr Ndom is a former President of AORTIC.
Council Member at Large
Dr Nicholas Anthony Othieno-Abinya
Dr Nicholas Anthony Othieno-Abinya is Professor of Medicine, head Haematology/Oncology Section, Department of Clinical Medicine and Therapeutics at the University of Nairobi. From January 2009 to December 2010 he was head of oncology at the Aga Khan University Hospital in Nairobi.
He holds a masters degree in internal medicine of the University of Nairobi, 1986, and completed his fellowship in medical oncology at the Royal London Hospital in 1992. He is also a Fellow of the Royal College of Physicians of Edinburgh.
Dr Othieno-Abinya’s main research interests are in haematologic malignancies , chemotherapy –induced haematopoietic dysfunction and breast cancer. He also takes keen interest in molecular oncology.
He has published widely in peer-reviewed journals and written a text book titled ‘Drug Treatment of Neoplastic Disorders of the Haematopoietic and Lymphoreticular System’, and contributed chapters in four text books. He is also the first author of three cancer awareness booklets published by the Nairobi University Press.
Dr Othieno-Abinya was AORTIC Vice President representing East Africa between November 2011 and November 2013 inclusive. He was founder member and first chairman of Kenya Society of Haematology and Oncology (KESHO). He has also been a member of ESMO from 1996 and ASCO from 1997. He was a member of the International Affairs Committee of ASCO between June 2009 and June 2002, and also a member of the Scientific Committee of African Journal of Cancer, and Chairman of Cancer Research and Communications Organisation, Nairobi, Kenya.
From 21/02/12 Dr Othieno-Abinya was secretariat head of sub-Saharan Africa chapter of National Comprehensive Cancer Network (NCCN), and chairman from 15/06/2013.
He was the Chair of the Technical Working Group of the Kenya National Cancer Management Guidelines which were launched on 06/11/2013.
Council Member at Large
Professor Adekunle Adesina
Adekunle M. Adesina, MD, Ph.D. is currently Professor of Pathology, Immunology and Pediatrics - Hematology / Oncology at Baylor College of Medicine, Houston, Texas. He also serves as the Medical Director of the Section of Neuropathology and Molecular Neuropathology Laboratory at the Texas Children’s Hospital, Baylor College of Medicine, Houston, TX.
He received his MD (MBBS) degree from the University of Ibadan, Nigeria and Ph.D. (Molecular Genetics / Molecular Neuro-oncology) from McGill University, Montreal, Canada. He completed residency training in Anatomic Pathology at the University College Hospital, Ibadan, Nigeria, Clinical Fellowship training in Anatomic Pathology and Neuropathology at the University of Vermont, a postdoctoral Research Fellowship at the Ludwig Institute for Cancer Research and Montreal Neurological Institute, Montreal, Canada, as well as a Fellowship in Surgical Pathology, Cytology and Molecular Pathology at the Fox Chase Cancer Center, Philadelphia. He served as attending Pathologist / Neuropathologist, as well as Clinical Director of Molecular Pathology Laboratories at The University of Oklahoma Health Sciences Center from 1994 - 2002.
Dr Adesina played a major role in the establishment of molecular diagnostics services and the teaching of molecular pathology to residents at the University of Oklahoma Health Sciences Center. He relocated to Baylor College of Medicine in August, 2002.
Dr Adesina also serves as the Chair for Pathology for the African Organization for Research and Training in Cancer (AORTIC) with responsibilities for the design and coordination of faculty presentations at the 2009, 2011 and 2013 7th, 8th and 9th biennial International conferences in Dar es Salam, Tanzania, Cairo, Egypt, and Durban South Africa, respectively.
Council Member at Large
Dr Twalib Ngoma
Dr Twalib A. Ngoma is the Executive Director of the Ocean Road Cancer Institute in Dar es salaam, Tanzania. In this position he supervises the day-to-day running of the Institute and advises the Ministry of Health in Tanzania on Cancer Control Policies. He is also the head of the Tanzania office of the International Network for Cancer Treatment.
Dr Carrie Hunter
Carrie P. Hunter, M.D., M.P.H. is President and CEO of Oncology Consulting International (OCI), LLC, a cancer care management, research, education and training consultancy company dedicated to improving cancer, non-communicable diseases (NCDs), and health outcomes. She collaborates with partners on projects and programs to advance prevention and treatment research, and supports education and training initiatives to build workforce capacity for cancer control and health care delivery.
Dr Hunter is experienced in strategic planning and evaluation of complex heath issues and in working across diverse cultures.
She is a graduate of New York University School of Medicine and is a board-certified medical oncologist. Post-graduate training was completed in internal medicine and hematology at Peter Bent Brigham Hospital (now the Brigham and Women’s Hospital) and in medical oncology at Dana Farber Cancer Institute, Boston, MA. She holds a Master in Public Health in Epidemiology from Johns Hopkins University School of Public Health, Baltimore, MD. She served as program director for the Community Clinical Oncology Program, Division of Cancer Prevention and Control, National Cancer Institute, National Institutes of Health (NIH), and as program director and project officer for the NIH Women’s Health Initiative. She has also worked in the private sector of the pharmaceutical industry.
Dr Hunter served on the Executive Council of the African Organisation for Research and Training in Cancer (AORTIC) (2000-2011) and was Vice President for the North America Region of AORTIC (2007-2011). She developed the AORTIC Strategic Plan. She was Chairperson of the AORTIC Scientific Program Committee for the 2003 4th International Conference on Cancer in Africa held in Accra, Ghana, which led to the re-activation and re-establishment of AORTIC on the African continent.
She is a member of Avon Foundation Scientific Advisory Board; the Board of the African Cancer Center, Lagos, Nigeria; and the Board of Governors of New York University School of Medicine. She is co-editor of two books: Cancer in the Elderly (2000) published by Marcel Dekker, Inc., New York; and Treatment and Management of Cancer in the Elderly (2006) published by Taylor & Francis Group, New York. She served on the Global Health Council’s Roundtable on NCDs that supported civil society/NGO efforts at the U. N. High Level Meeting on NCDs in September, 2011.
Dr James Holland
Dr James F. Holland met with Dr Victor Anomah Ngu, an old friend, then Dean of the Ibadan School of Medicine, Dr Christopher Williams, Oncologist at Ibadan, a former student of Dr Holland"s, and the late Dr Tori Solanke, Professor of Surgery at Ibadan at the International Cancer Congress in Seattle in 1984. Out of a pleasant reunion sprang the idea for AORTIC.
Dr Holland attended Princeton University and Columbia University’s College of Physicians and Surgeons. He worked at the National Cancer Institute and at Roswell Park Cancer Institute before joining the faculty of Mount Sinai School of Medicine as Director of the Cancer Center in 1973, where he still works. He was a founder and Chairman of the Cancer and Leukemia Group B, and has been elected to the Presidency of the American Association for Cancer Research and of the American Society of Clinical Oncology. The text Holland -Frei Cancer Medicine is in its 6th Edition.
Dr James Holland is married to Dr Jimmie Holland. They have six children and six grandchildren.
Professor Seth Ayettey
Seth Ayettey is a Professor of Anatomy with a PhD from the University of Cambridge and a MBChB degree from the University of Ghana. His research interest lies in the study of the ultrastructure of vertebrate cardiac muscles with special reference to the transverse tubular system, innervation, cell junctions and distribution of cytoplasmic organelles. The Primary aim of these studies is to determine morphometric differences in cardiac cells of mammalian and non-mammalian vertebrate species and the possible relationship of these to design and function of the cardiac myocyte.
Professor Ayettey is a minister of the Presbyterian Church of Ghana and member of the Board of Directors of World Vision and of the Executive Committee of that Board, Chairman of the Prison Council in Ghana and Honorary Member of AORTIC Africa.
Dr Christopher Williams
Christopher Williams, MD, FRCPC, FWACP, DABIM, is a dual citizen of Nigeria and Canada and had his bas ic medical education at the University of Munich, Germany. He obtained his postgraduate medical training at the University of Western Ontario, London, Ontario, Canada where he trained in Internal Medicine, followed by training in Clinical Haematology at the McMaster University, Hamilton, Ontario, Canada and in Medical Oncology at the Mount Sinai School of Medicine in New York, NY, USA.
He then returned to Nigeria to work at the University College Hospital, Ibadan, Nigeria and was on the faculty of the College of Medicine of the University of Ibadan from 1978 to 1986. During this period, he served the institution as the Foundation Subdean of the Faculty of Basic Science and Pharmacy.
It was during this period that he teamed up with two senior African colleagues, Dr Victor Ngu of the Cameroon, and Dr Toriola Solanke of Nigeria, and his American mentor, James F. Holland, to found the African Organisation for Research and Training in Cancer (AORTIC), serving the organization as its Founding Secretary-General. In 2000 he was involved in the process of reactivating the then moribund AORTIC, thereby helping to create AORTIC International, which has recently succeeded in reactivating the Africa-based organization.
Dr Williams, who has practiced medicine in Africa, Asia, Europe and North America, has published about 100 scientific articles in peer-reviewed journals, abstracts in international conference proceedings and chapters in books. He is the Editor-in-Chief of the book “Breast Cancer in Women of African Descent”, which is about to be published by Spinger. He is a pioneer researcher in clinical retrovirology in Africa and was the first biomedical researcher to alert Africa’s most populous country, Nigeria, to the earliest epidemiological data of HIV/AIDS.
His work in Nigeria also encompasses the earliest attempt to establish Medical Oncology as a discipline in a major Sub-Saharan Hospital.